Kristian Schroder Hart-hansen MS

Kristian Hart-Hansen is the CEO of the LEO Innovation Lab, an independent unit of LEO Pharma, established to cultivate new technology to enable patients to prevent, detect and manage chronic skin conditions. Under Kristian’s leadership, LEO Innovation Lab has built several innovative digital platforms, leveraging technology such as AI, and real-time data collection. Kristian’s vision is to nurture a clinical journey that is more adaptable, patient-driven, and most importantly, more efficient.